Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 06/01/2012
PIL Nasonex 50 micrograms/actuation Nasal Spray, Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 04/11/2011 and displayed until 06/01/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 11/08/2011 and displayed until 04/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 26/01/2011 and displayed until 11/08/2011
Reasons for adding or updating:
  • Company name change or merger
  • Change to date of revision
Updated on 26/01/2010 and displayed until 26/01/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Introduction of new pack/pack size
Updated on 28/06/2007 and displayed until 26/01/2010
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   mometasone furoate monohydrate